Salicylate (Salsalate) in Patients With Type 2 Diabetes:
Clinical Trials Wednesday, July 3rd, 2013Annals of Internal Medicine – 2 July 2013
Background: Short-duration studies show that salsalate improves glycemia in type 2 diabetes mellitus (T2DM).
Objective: To assess 1-year efficacy and safety of salsalate in T2DM.
Design: Placebo-controlled, parallel trial; computerized randomization and centralized allocation, with patients, providers, and researchers blinded to assignment. (ClinicalTrials.gov: NCT00799643)
Setting: 3 private practices and 18 academic centers in the United States.
Patients: Persons aged 18 to 75 years with fasting glucose levels of 12.5 mmol/L or less (≤225 mg/dL) and hemoglobin A1c (HbA1c) levels of 7.0% to 9.5% who were treated for diabetes. Read more
